propranolol has been researched along with 2,3-dinor-6-ketoprostaglandin f1alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wennmalm, A | 1 |
| Beckmann, ML; Gerber, JG; Nies, AS | 1 |
2 trial(s) available for propranolol and 2,3-dinor-6-ketoprostaglandin f1alpha
| Article | Year |
|---|---|
Formation of prostacyclin during administration of beta 1-selective and non-selective beta-adrenergic antagonists in healthy humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic beta-Antagonists; Adult; Blood Pressure; Epoprostenol; Female; Heart Rate; Humans; Male; Metoprolol; Middle Aged; Propranolol; Receptors, Adrenergic, beta | 1992 |
Prostacyclin synthesis is increased during propranolol therapy for essential hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Blood Pressure; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indomethacin; Male; Propranolol; Random Allocation | 1989 |